FFCP PHASE1:Mm9::chr2:156282978..156282979,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=239|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr2:156282978..156282979,+|id=chr2:156282978..156282979,+|ontology_enrichment_celltype=CL:0000068!6.04e-65!3;CL:0002202!6.04e-65!3;CL:0000069!6.04e-65!3;CL:0002632!6.04e-65!3;CL:0002368!6.04e-65!3;CL:0000307!6.04e-65!3;CL:0000377!6.04e-65!3;CL:0000057!3.06e-23!1;CL:0000632!3.06e-23!1;CL:0002076!7.25e-14!15;CL:0000223!1.24e-10!20;CL:0000066!1.11e-08!25;CL:0000151!1.13e-08!3;CL:0000499!1.13e-08!3;CL:0000327!1.13e-08!3|ontology_enrichment_celltype_v019_2=CL:0000057,3.07e-86,1;CL:0000632,3.07e-86,1;CL:0000151,5.61e-30,3;CL:0000499,5.61e-30,3;CL:0000327,5.61e-30,3|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0003126!6.04e-65!3;UBERON:0001005!6.04e-65!3;UBERON:0007196!6.04e-65!3;UBERON:0001558!6.04e-65!3;UBERON:0005178!2.40e-12!17;UBERON:0005181!2.40e-12!17;UBERON:0002224!2.40e-12!17;UBERON:0000915!2.40e-12!17;UBERON:0008947!2.40e-12!17;UBERON:0003258!2.40e-12!17;UBERON:0000072!4.25e-08!27|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.185510400758,0,0,0,0,0,0,0,0,0,0,0,0,0.216491041011214,0.760079596425296,0.505524445014783,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr2:156282978..156282979,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=239 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr2:156282978..156282979,+ | |||
|description=CAGE_peak_at_chr2:156282978..156282979,+ | |||
|id=chr2:156282978..156282979,+ | |||
|ontology_enrichment_celltype=CL:0000068!6.04e-65!3;CL:0002202!6.04e-65!3;CL:0000069!6.04e-65!3;CL:0002632!6.04e-65!3;CL:0002368!6.04e-65!3;CL:0000307!6.04e-65!3;CL:0000377!6.04e-65!3;CL:0000057!3.06e-23!1;CL:0000632!3.06e-23!1;CL:0002076!7.25e-14!15;CL:0000223!1.24e-10!20;CL:0000066!1.11e-08!25;CL:0000151!1.13e-08!3;CL:0000499!1.13e-08!3;CL:0000327!1.13e-08!3 | |||
|ontology_enrichment_celltype_v019_2=CL:0000057,3.07e-86,1;CL:0000632,3.07e-86,1;CL:0000151,5.61e-30,3;CL:0000499,5.61e-30,3;CL:0000327,5.61e-30,3 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0003126!6.04e-65!3;UBERON:0001005!6.04e-65!3;UBERON:0007196!6.04e-65!3;UBERON:0001558!6.04e-65!3;UBERON:0005178!2.40e-12!17;UBERON:0005181!2.40e-12!17;UBERON:0002224!2.40e-12!17;UBERON:0000915!2.40e-12!17;UBERON:0008947!2.40e-12!17;UBERON:0003258!2.40e-12!17;UBERON:0000072!4.25e-08!27 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.185510400758,0,0,0,0,0,0,0,0,0,0,0,0,0.216491041011214,0.760079596425296,0.505524445014783,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr2:156282978..156282979,+ | |||
}} |
Latest revision as of 08:59, 4 August 2015
Short description: | p@chr2:156282978..156282979, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr2:156282978..156282979, + |
Coexpression cluster: | MCL_coexpression_mm9:239 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
fibroblast | 3.07e-86 | 1 |
hepatic stellate cell | 3.07e-86 | 1 |
secretory cell | 5.61e-30 | 3 |
stromal cell | 5.61e-30 | 3 |
extracellular matrix secreting cell | 5.61e-30 | 3 |